Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...

A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.

The first daily weight-loss pill is expected to be available in the UK as soon as 2026 after a trial found it to be effective ...

One solution some policymakers may try is restricting the number of people on Medicaid who can use the pricey diabetes drugs ...

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

Wegovy has been shown in trials to deliver average weight loss of around 15 per cent in patients with obesity alongside a reduced-calorie diet and increased physical activity. It comes in a device ...

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...